FW: (BFW) Avalanche Bio Falls After Scrapping Plans for Ph (Vahe Stepanian, 8/14/2015)EFTA Document EFTA01368504
1 duplicate copy in the archive
EFTA Document EFTA01368503
Title Matchefta-efta01368503
Case Filesd-10-EFTA01368503Dept. of JusticeEFTA Document EFTA01368503
Unknown1p
Case File
sd-10-EFTA01368503Dept. of JusticeEFTA Document EFTA01368503
Other
request. PZM 08/13 20:05 Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on AVA-101 Program BFW 08/13 20:24 "AVALANCHE WON'T START A PHASE 2B TRIAL OF AVA-101 FOR WET AMD BN 08/13 20:24 *AVALANCHE WONT START A PHASE 26 TRIAL OF AVA-101 FOR WET AMD BN 08/13 20:24 *AVALANCHE WONT STARTA PHASE 2B TRIAL OF AVA-101 FOR WET AMD BN 08/13 20:24 *AVALANCHE WON'T INITIATE PHASE 26 TRIAL BN 08/13 20:19 *AVALANCHE BIOTECHNOLOGIES 2Q REV $0.2M, EST. $0.4
Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01368503
Pages
1
Persons
0
Integrity
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,800+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.